Atlas Trials

The Effects of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib

Clinical trial NCT02800330 · COMPLETED

Trial details

NCT number
NCT02800330
Sponsor
Erasmus Medical Center
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Colorectal NeoplasmsGastrointestinal Stromal Tumors
Start date
2016-05-01
Primary completion
2018-02-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.